Latest News about LEGN
Recent news which mentions LEGN
From Benzinga
As China's Population Declines In 2023, Will Aging Demographics Boost Healthcare Stocks?
January 10, 2024
From Benzinga
Blood Cancer Player Arcellx Finds Place On Analyst Conviction List - Potential Room For Growth In 2024
January 04, 2024
From Benzinga
From Benzinga
From Benzinga
Bristol Myers Squibb, 2seventy bio shares fall as FDA delays action on cancer treatment
November 20, 2023
From MarketWatch
Earnings Scheduled For November 20, 2023
November 20, 2023
From Benzinga
Looking for Stocks to Buy? Here Are the Companies Johnson & Johnson Is Betting the Most On
November 16, 2023
From Motley Fool
Positive Outlook On Johnson & Johnson's Partner Legend Biotech: Analyst Confident On Blood Cancer Drug
October 18, 2023
From Benzinga
3 Biotech Stocks That Analysts Are Drooling Over
August 07, 2023
From InvestorPlace
Legend Biotech's Breakthrough in Multiple Myeloma Study Prompts Positive Analyst Forecast
June 06, 2023
Tickers
LEGN
From Benzinga
Analyst's Verdict on Legend Biotech: Doubts On Commercial Execution, Long- Term Market Share
May 25, 2023
Tickers
LEGN
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Johnson & Johnson Ignites CAR-T Ambitions With Licensing Pact With Cellular Biomedicine
May 02, 2023
From Benzinga
Tickers
LEGN
From Motley Fool
Potential Breakout Setups To Watch On Wednesday
April 26, 2023
From Benzinga
Why Shares of Geron Are Up 30% This Week
April 20, 2023
From Motley Fool
Where Is The Current Bull Market? Scan Of Stocks Gaining Over 20% Over The Past Week Almost Exclusively Yields Biotech Names
April 20, 2023
From Benzinga
7 Biotech Stocks That Could Cure Your Portfolio Woes
April 19, 2023
From InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
April 19, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.